Ministry of Food and Drug Safety 국민 안심이 기준입니다 YOUR SAFETY IS OUR STANDARD

Ministry of Food and Drug Safety 국민 안심이 기준입니다 YOUR SAFETY IS OUR STANDARD

home > Information > News&Notice > News&Notice
News&Notice|News&Notice|Information|Ministry of Food and Drug Safety

News&Notice

[Press Release] MFDS, Published English Assessment Summaries of Locally Developed Biosimilars
  • Registration Date 2023-12-22
  • Hit 8929

- Two Home-grown Lucentis Biosimilars Added to List of English Assessment Summaries of MFDS-approved Biosimilars




The Ministry of Food and Drug Safety (Minister OH Yu-Kyoung) announced that the English assessment summary information of two Korean Lucentis biosimilars (ranibizumab)* to treat age-related macular degeneration was disclosed at the MFDS website.


* Amelivu inj. (Samsung Bioepis), Chong Kun Dang Ranibizumab inj. (Chong Kun Dang)






첨부파일


붙임

Attached File
  • (ENG)Press Release_PASIB.pdf Download preview

Division 유전자재조합의약품과

Written by 최예진

Telephone 043-719-3509